Essais liés2clinical trials
VilleNîmeslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07074886

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Ocrelizumab SEP Phase 3 NCT04035005 O'HAND — A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis ACTIVE_NOT_RECRUITING
Ocrelizumab Test Formulation SEP Phase 2 NCT07074886 PORTAMENTO — A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) ACTIVE_NOT_RECRUITING